Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)

Arnt V. Kristen, Mathew S. Maurer, Claudio Rapezzi, Rajiv Mundayat, Ole B. Suhr, Thibaud Damy, Fabio Adrian Barroso, Marcelo F. Rugiero, Johan J. Van Cleemput, Ivailo Tournev, Marcia Waddington Cruz, Nowell M. Fine, Arnt Volko Kristen, Hartmut H.J. Schmidt, Tim Zimmermann, Burkhard Gess, Henning Moelgaard, Josep Maria Campistol Plana, Juan Buades Reines, Jose Gonzalez CostelloPablo Garcia Pavia, Jose Luis Munoz Blanco, Violaine Plante-Bordeneuve, David Adams, Jocelyn Inamo, Giuseppe Vita, Giampaolo Merlini, Franco Bergesio, Yoshiki Sekijima, Yukio Ando, Sonoko Misawa, Ga Yeon Lee, Jeeyoung Oh, Maria Alejandra Gonzalez Duarte Briseno, Bouke P.C. Hazenberg, Teresa Coelho, Isabel M. Conceicao, Mathew Shane Maurer, Sanjiv Jayendra Shah, Dianna Quan, Daniel Philip Judge, Stephen Scott Gottlieb, Nitasha Sarswat, Srinivas C. Murali, Stanley Iyadurai, William Gerritt Cotts, Brian M. Drachman, Angela Dispenzieri, David Eric Steidley, Scott L. Hummel, on behalf of the THAOS investigators

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds